---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-112442"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:00:59.585892+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BrainStorm regains Nasdaq minimum bid price compliance; listing continues

## Summary
- Received Nasdaq notice of compliance on Oct 29, 2024; common stock continues on Nasdaq Capital Market.
- Effected 1-for-15 reverse stock split on Sep 30, 2024 to regain compliance.
- Stock closed above $1.00 for ten consecutive trading days as of Oct 15, 2024.
- Previously faced delisting; Nasdaq hearing panel granted temporary exception until Oct 21, 2024.

## SEC filing metadata
- accession: 0001104659-24-112442
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924112442/0001104659-24-112442-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924112442/tm2427087d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-112442
- JSON: https://secwatch.observer/filing/0001104659-24-112442.json
- Plain text: https://secwatch.observer/filing/0001104659-24-112442.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.